General Commentary
Published on 19 Aug 2014
Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00254
- 3,699 views
- 3 citations
Type at least 3 characters
1,001 articles
Articles
Opinion
Published on 17 Jul 2014
Role of glutamate transporter 1 in the attenuation of alcohol intake
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00200
- 4,576 views
- 6 citations
Review
Published on 24 Jun 2014
P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00176
- 9,761 views
- 47 citations
Original Research
Published on 13 Jun 2014
CamKII inhibitors reduce mitotic instability, connexon anomalies and progression of the in vivo behavioral phenotype in transgenic animals expressing a mutated Gjb1 gene
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00151
- 5,199 views
- 10 citations
Editorial
Published on 12 Jun 2014
Opportunities and perspectives for developing orexin receptor antagonists
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00158
- 4,974 views
- 4 citations
Review
Published on 06 Jun 2014
GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00140
- 16,108 views
- 88 citations
Review
Published on 03 Jun 2014
Targeting central melanocortin receptors: a promising novel approach for treating alcohol abuse disorders
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00128
- 7,767 views
- 27 citations
Original Research
Published on 27 May 2014
Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00129
- 7,417 views
- 65 citations
Review
Published on 22 May 2014
Advances in non-dopaminergic treatments for Parkinson's disease
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00113
- 25,224 views
- 87 citations
Original Research
Published on 20 May 2014
Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortex
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00107
- 5,452 views
- 7 citations
Review
Published on 06 May 2014
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00057
- 18,525 views
- 59 citations
Hypothesis and Theory
Published on 08 Apr 2014
The EEG as an index of neuromodulator balance in memory and mental illness
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00063
- 112,183 views
- 40 citations
Review
Published on 25 Feb 2014
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00036
- 19,108 views
- 83 citations
Original Research
Published on 25 Feb 2014
Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00033
- 9,087 views
- 81 citations
Original Research
Published on 14 Feb 2014
Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00028
- 9,238 views
- 62 citations
Mini Review
Published on 13 Feb 2014
Orexin 1 receptor antagonists in compulsive behaviour and anxiety: possible therapeutic use.
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00026
- 16,535 views
- 58 citations